DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding DiaMedica Therapeutics Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 26 | 28 | +2 |
| Shares | 2.53M | 2.52M | −5.00K (−0.2%) |
| Value | $3.14M | $3.99M | +$855.1K (+27.3%) |
New holders (5)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 33,619 | $53.0K | 0.00% |
| Catalyst Financial Partners LLC | 14,475 | $22.9K | 0.01% |
| Advisory Services Network, LLC | 1,500 | $2.37K | 0.00% |
| BNP Paribas Arbitrage, SA | 600 | $948 | 0.00% |
| Bank of America Corp | 40 | $64 | 0.00% |
Sold out (3)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 35,258 | $44.0K |
| Two Sigma Advisers, LP | 24,900 | $31.0K |
| HRT Financial LP | 10,441 | $12.0K |